Collaborate, Network, and Learn
The 3-day virtual event is packed with opportunities to connect with peers, meet members of the AONN+ Leadership Council and/or Committee Chairs, share best practices, and get a glimpse of the latest innovations from exhibitors to aid in providing optimal patient care.
Attendees will have the opportunity to earn up to 12 continuing education contact hours over the conference’s 3-day span. Our agenda includes informative sessions on disease state discussions and practical solutions to daily navigation challenges, and accredited content.
Agenda*
On-Demand Sessions
On-Demand
Breakout Session 1 | How to Develop a Successful Lung Cancer Screening Program: Using an Engaged Approach
Jamie Studts, PhD
Karen Wilson, MN, RN, ONN-CG, CGRN, CTTS
Kaitlyn Hoover
On-Demand
Breakout Session 2 | Navigating a Rare Disease: A Case Study
Ann MacMullan, C-IAYT, E-RYT 500
Kate Mimken, BSN, RN, NP-C
Paula Adams, BS, MS, RN (WM Survivor)
On-Demand
Breakout Session 3 | How Navigation Can Educate and Empower the Adult Primary Brain Tumor Patient
Laura D. Hynes, MA, BSN, BA, RN
Cassie Latino, MSN, RN, ONN-CG
Jimmy Bates, MBA (GBM Survivor)
Wednesday, May 14
10:45 am - 11:00 am Eastern Time
Opening Remarks (non‑CE)
Candice Roth, MSN, RN, CENP
Clara Lambert, OPN-CG
Kristina Rua, MSN, RN, OCN, ONN-CG
11:00 am - 12:00 pm Eastern Time
General Session 1 | Show Me the Money: The Business Case for Navigation
Judy Moore, MSN, RN, OCN, NEA-BC
Elizabeth Garcia, MPA, BSN, RN, NEA-BC, CPXP
Carol Lewis, MD, MPH
Bill Atkinson, MBA, MBH
12:00 pm - 1:00 pm Eastern Time
Product Theater 1 | Presentation by Amgen
Breakthrough Innovation: The First and Only Bispecific T-cell Engager (BiTE®) Therapy for 2L+ Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (non‑CE)
Sarah Karpen, PA-C
1:00 pm - 1:15 pm Eastern Time
Break
1:15 pm - 2:15 pm Eastern Time
General Session 2 | Cancer-Related Fatigue: The What, Why, and How to Mitigate
Jenny Spencer, RN, BSN, OCN, CPT, CETI CES
2:15 pm - 3:15 pm Eastern Time
Product Theater 2 | Presentation by Pfizer: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination With a PD-1 Inhibitor for 1L LA/MUC (non‑CE)
Julia Batten, APRN, MSN, MPH
3:15 pm - 4:15 pm Eastern Time
General Session 3 | Proactive Financial Navigation Interventions: Its Role in Treating Financial Toxicity
Dan Sherman, MA, LPC
Thursday, May 15
9:45 am - 10:00 am Eastern Time
Opening Remarks & Day 1 Highlights (non‑CE)
Clara Lambert, OPN-CG
Kristina Rua, MSN, RN, OCN, ONN-CG
10:00 am - 11:00 am Eastern Time
Product Theater | Presented by Pfizer:
A Biomarker-Directed Treatment Option for ALK-Positive Metastatic NSCLC
(non‑CE)
Martin F. Dietrich, MD, PhD
11:00 am - 12:00 pm Eastern Time
General Session 4 | Navigating Care Together: How Nonprofits, Social Workers, and Nurse & Patient Navigators Guide the Patient Journey.
Zarek Mena, OPN-CG
Sandra Morales, OPN-CG
Vilmarie Rodriguez, MSW, LCSW
Tricia Strusowski, MS, RN
Angelique Caba, LCSW-R
12:00 pm - 1:00 pm Eastern Time
Product Theater 3 | Presentation by AstraZeneca: Guidance for Management of Adverse Reaction in HR+/HER- aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET +/- CDK4/6i (non‑CE)
Samantha Cinadr, MSN, APRN, AGNP-BC, OCN
1:00 pm - 1:15 pm Eastern Time
Break
1:15 pm - 2:15 pm Eastern Time
General Session 5 | Navigation Reimbursement
Jackie Miller, MSN, RN, OCN
2:15 pm - 3:15 pm Eastern Time
Navigating a Changing Access Landscape
Brought to you by Pfizer
(non‑CE)
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Kristin Manzolillo, MPH, US Patient Solutions Strategy Lead, Pfizer
3:15 pm - 4:15 pm Eastern Time
General Session 6 | International Navigation
Linda Burhansstipanov, DrPH, MSPH, OPN-CG
Nancy Pena, ACS-LION, OPN-CG, CMI, CWH
Friday, May 16
10:45 am - 11:00 am Eastern Time
Opening Remarks & Day 2 Highlights (non‑CE)
Clara Lambert, OPN-CG
Kristina Rua, MSN, RN, OCN, ONN-CG
11:00 am - 12:00 pm Eastern Time
General Session 7 | What Is Healing and How to Elicit and Cultivate Your Innate Healing Gifts, and Encourage the Same in Your Patients
Laura Pole, MSN, BSN, OCNS
12:00 pm - 1:00 pm Eastern Time
Product Theater 4 | Presentation by Eli Lilly and Company
Peer insights to help identify and manage candidates for treatment with a CDK4/6 inhibitor.
© Lilly USA, LLC 2025. All rights reserved.
(non‑CE)
Blanca Ledezma, MSN, NP
1:00 pm - 2:00 pm Eastern Time
Rooted in Purpose, Reaching for the Future: The Vision of AONN+
~ Come Meet the New AONN+ Board President
Candice Roth, MSN, RN, CENP
2:00 pm - 2:15 pm Eastern Time
Break
2:15 pm - 3:15 pm Eastern Time
General Session 8 | Preserving Reproductive Health for Patients With Cancer: Insights From an Oncofertility Patient Navigator
Kristin Smith, BS
3:15 pm - 4:15 pm Eastern Time
General Session 9 | Policy & Advocacy: Current Issues Around Patient Support
Fabian Robles, MSc, CHI
Elizabeth Franklin, PhD, MSW
4:15 pm - 4:30 pm Eastern Time
Closing Remarks (non‑CE)
Monica Dean
Candice Roth, MSN, RN, CENP
*Subject to change.
Midyear Conference 
